capecitabine monotherapy

capecitabine monotherapy

ID:22871709

大小:108.50 KB

页数:27页

时间:2018-11-01

capecitabine monotherapy_第1页
capecitabine monotherapy_第2页
capecitabine monotherapy_第3页
capecitabine monotherapy_第4页
capecitabine monotherapy_第5页
资源描述:

《capecitabine monotherapy》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库

1、CapecitabineMonotherapy【关键词】Capecitabine,#8226;,Breast,cancer,#8226;,Single,agent,#8226;,Monotherapy,#8226;,Efficacy,#8226;,Safety,#8226;,Quality,of,life  LEARNINGOBJECTIVES  Afterpletingthiscourse,thereaderacologyofcapecitabine.  Discusstheuseofcapecitabineasasin

2、gleagentandinrefractorydisease.  Discusssafetyanddosingconsiderations  Describecurrentadjuvanttreatmentalmanagementformetastaticbreastcancerfrequentlyinvolvescytotoxicchemotherapy.Overtheyears,severalplexmultidrugregimenshavebeendevelopedthatoractivityandnonoverla

3、ppingtoxicities.Hoenshasbeencalledintoquestionasseveraldrugsusedalone(monotherapy)orinsequence(serialsingleagent)havebeenshoinisteredfluoropyrimidinecarbamate)isonesuchagentthathasbeenproventobeeffectiveetastaticbreastcancer,metastaticcolorectalcancer,andadjuvantc

4、oloncancer.Inthisrevie)dataexaminingvariousaspectsofclinicalresponseandtolerabilityarily)first-andsecond-linemetastaticbreastcancerareexamined.Forthemostpart,responseratesareparableoreplexregimens.Dosereductionsfromthelabeleddoseof1,250mg/m2ton.Toxicities(folloana

5、geable,evenbymorefrailpatients.Elderlypatientsaremorelikelytohaveimpairedrenalfunctionorbereceivingent,andspecialattentiontothesefactorsisinisteredaloneisareasonablechoiceotherapyisentertainedasatreatmentoptionformetastaticbreastcancer,includinginthefirst-linesett

6、ing.  INTRODUCTION  Breastcanceristhemostfrequentlydiagnosedcancerinenandthesecondleadingcauseofcancer-relateddeaths(follo98%inlocalizeddiseaseto80%etastaticdisease.Chemotherapyplaysanimportantroleinbreastcancer,etastaticsetting.Singlechemotherapeuticagentsinclude

7、dintheNationalprehensiveCancerNetaldoxorubicin),taxanes(e.g.,paclitaxel,docetaxel),vinorelbine,andcapecitabine,eachofaybeusedasasingleagent6789101112131415forrecurrentormetastaticdisease[2].Amongthetaxanes,forexample,single-agentpaclitaxelhasbeenshootherapy-na&ium

8、l;ve)patientsetastaticdisease,yieldingresponseratesof25%34%[35],etastaticsettings,otherapy-naïvepatients[9]and17%23%inpatientsotherapy[1012].Contin

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。